US Archives - Page 7 of 205 - European Medical Journal

Pregnant patient receiving prenatal care during a clinical appointment.

Gestational Syphilis Reveals Prenatal Care Failures

Gestational syphilis exposed gaps in prenatal care, from missed education to delayed diagnosis and partner treatment.

Clinician discussing darolutamide cognitive decline data with a patient with prostate cancer.

ASCO 2026: Darolutamide Shows Cognitive Edge in Prostate Cancer

Darolutamide showed less cognitive decline than enzalutamide in ARACOG results presented at ASCO 2026 for prostate cancer.

Patient using a smartphone while holding a medication bottle, representing mobile health apps for lupus erythematosus disease management.

Patient-Centered Lupus Apps Show Clinical Potential

Lupus erythematosus mobile apps may support disease management, but a systematic review found few meet patient-centered standards.

Child undergoing knee assessment for rice body synovitis and juvenile idiopathic arthritis evaluation.

Joint Swelling in Children May Signal Arthritis

Rice body synovitis in children is most often linked to juvenile idiopathic arthritis, pooled evidence suggests.

Patient consulting oncologist about head and neck cancer treatment options.

ASCO 2026: New First-Line Option Emerges in Head and Neck Cancer

Head and neck cancer survival improved with TMC-I versus platinum chemotherapy in recurrent or metastatic disease.

Contrast-enhanced mammography equipment used to assess breast cancer response after neoadjuvant therapy.

Can Contrast-Enhanced Mammography Rival MRI in Breast Cancer Care?

Contrast-enhanced mammography showed good accuracy for assessing breast cancer response after neoadjuvant therapy in pooled data.

Person with Parkinson’s disease discussing daily life after deep brain stimulation with a clinician.

Parkinson’s Disease Surgery Restores Daily Independence

Parkinson’s disease patients described restored autonomy after STN-DBS, while still fearing symptom recurrence in daily life after surgery.

Doctor discussing TALAPRO-3 prostate cancer treatment options with a patient.

ASCO 2026: TALAPRO-3 Delays Prostate Cancer Progression

TALAPRO-3 data show talazoparib plus enzalutamide delayed progression in HRR-deficient metastatic castration-sensitive prostate cancer.

Healthcare professional using an electronic medical record alert to support chlamydia screening in primary care.

Chlamydia Screening Alert Boosts Primary Care Testing

Chlamydia screening increased in primary care when medical assistants received real-time electronic medical record alerts.

Blurred hospital corridor representing clinical outcomes after private equity hospital acquisition.

Private Equity Hospitals See More Asthma Revisits

Private equity hospitals saw worse pulmonary outcomes after acquisition, with higher asthma and COPD revisit rates.